torrent pharmaceuticals
Jump to
457 Results Found
  • Torrent Pharma gets green nod for Rs 300 cr project Nov 06, 2017 01:53 PM IST

    Torrent Pharma gets green nod for Rs 300 cr project

    The Union Environment Ministry issued the environment clearance certificate for the proposed project saying that the approval has been given with certain riders. The Ahmedabad-based firm's unit will cover 57,737 sq mt area in Kalol taluk.

  • Unichem-Torrent deal positive for both companies: Surajit Pal Nov 06, 2017 10:05 AM IST

    Unichem-Torrent deal positive for both companies: Surajit Pal

    Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal for Rs 3,600 crore.

  • Torrent sharpens focus on Indian market with Unichem’s brands – time to lock in? Nov 06, 2017 08:03 AM IST

    Torrent sharpens focus on Indian market with Unichem’s brands – time to lock in?

    The deal marks the fifth acquisition for Torrent. In 2014, Torrent had acquired a set of Elder brands. In the past few years it has acquired manufacturing plants from ZygPharma and Glochem industries and few brands from Novartis.

  • M&A in 2017: Best in a decade Nov 03, 2017 09:14 PM IST

    M&A in 2017: Best in a decade

    The Torrent Pharmaceuticals and Unichem Laboratories deal is close to fruition. On a day this Rs 3600 crore deal has been sealed, it is a good time to look at M&A activity in 2017 so far. In an interview to CNBC-TV18, Raja Lahiri of Grant Thornton, Randhir Kochhar of Ernst & Young, Vivek Gupta of KPMG and Ashvin Parekh of Ashvin Parekh Advisory Services discussed about the same.

  • Torrent Pharma Q2 net dips 1.44% to Rs 204 cr Nov 03, 2017 06:43 PM IST

    Torrent Pharma Q2 net dips 1.44% to Rs 204 cr

    The company had posted a net profit of Rs 207 crore in the same period a year ago, Torrent Pharmaceuticals said in a BSE filing.

  • Torrent Pharma Q2 profit declines 1.4% to Rs 204 crore on pricing pressures in US business Nov 03, 2017 05:42 PM IST

    Torrent Pharma Q2 profit declines 1.4% to Rs 204 crore on pricing pressures in US business

    The US sales dropped 21 percent to Rs 255 crore in Q2 due to continued price erosion and customer consolidation, while domestic formulation business grew 22.4 percent to Rs 607 crore on recovery of channel inventory impacted by GST transition.

  • Torrent to acquire Unichem's domestic branded business for Rs 3,600 crore Nov 03, 2017 05:19 PM IST

    Torrent to acquire Unichem's domestic branded business for Rs 3,600 crore

    Torrent will fund the acquisition through a mix of internal accruals and bank borrowings.

  • Torrent Pharma eyes Unichem's domestic business Oct 30, 2017 02:10 PM IST

    Torrent Pharma eyes Unichem's domestic business

    There is a mega deal brewing in the pharma space. CNBC-TV18 learns that Torrent Pharmaceuticals is in advance talks to buy Unichem Laboratories' domestic business.

  • Cadila Healthcare and Torrent Pharma deny merger talks Aug 21, 2017 04:03 PM IST

    Cadila Healthcare and Torrent Pharma deny merger talks

    Business news channel ET Now had aired a report which said that the companies are evaluating a potential merger.

  • Buy Torrent Pharmaceuticals; target of Rs 1460: Edelweiss Aug 01, 2017 07:07 PM IST

    Buy Torrent Pharmaceuticals; target of Rs 1460: Edelweiss

    Edelweiss is bullish on Torrent Pharmaceuticals has recommended Buy rating on the stock with a target price of Rs 1460 in its research report dated July 31, 2017

  • Torrent Pharmaceuticals Q1 net down 35.62% at Rs 188 cr Jul 31, 2017 04:27 PM IST

    Torrent Pharmaceuticals Q1 net down 35.62% at Rs 188 cr

    The company had posted a consolidated net profit of Rs 292 crore in the same quarter previous fiscal, Torrent Pharmaceuticals Ltd said in a BSE filing.

  • Torrent Pharma falls over 3.5% as US FDA issues 5 observations to Dahej plant Jul 11, 2017 09:18 AM IST

    Torrent Pharma falls over 3.5% as US FDA issues 5 observations to Dahej plant

    The plant was inspected by the US Food and Drug Administration between June 26 and 30.

  • Sell Arvind, Torrent Pharma; buy L&T, Asian Paints, Hero Moto: Sudarshan Sukhani Jun 08, 2017 09:53 AM IST

    Sell Arvind, Torrent Pharma; buy L&T, Asian Paints, Hero Moto: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may sell Arvind and Torrent Pharmaceuticals and can buy Larsen & Toubro, Asian Paints and Hero MotoCorp.

  • Buy Torrent Pharmaceuticals; target of Rs 1570: Edelweiss Jun 02, 2017 03:51 PM IST

    Buy Torrent Pharmaceuticals; target of Rs 1570: Edelweiss

    Edelweiss is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1570 in its research report dated May 29, 2017.

  • Hold Torrent Pharmaceuticals; target of Rs 1200: ICICI Direct May 29, 2017 05:41 PM IST

    Hold Torrent Pharmaceuticals; target of Rs 1200: ICICI Direct

    ICICI Direct recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1200 in its research report dated May 29, 2017.

  • HDFC Securities positive on Divis, Cadila; neutral on Sun Pharma May 29, 2017 09:48 AM IST

    HDFC Securities positive on Divis, Cadila; neutral on Sun Pharma

    In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on a few of the pharma stocks.

  • Sell IndusInd Bk, Torrent Pharma, Coal India; buy Adani Ports, Escorts: Sukhani May 22, 2017 10:07 AM IST

    Sell IndusInd Bk, Torrent Pharma, Coal India; buy Adani Ports, Escorts: Sukhani

    Sudarshan Sukhani of s2analytics.com suggests selling IndusInd Bank, Torrent Pharmaceuticals and Coal India and advises buying Adani Ports and Special Economic Zone and Escorts.

  • USFDA issues 4 observations for Torrent Pharma's Indrad plant May 12, 2017 07:50 PM IST

    USFDA issues 4 observations for Torrent Pharma's Indrad plant

    Drug firm Torrent Pharmaceuticals today said the US health regulator has issued four observations after inspection of its Indrad facility in Gujarat.

  • Top buzzing midcap stocks to trade on April 10 Apr 10, 2017 12:45 PM IST

    Top buzzing midcap stocks to trade on April 10

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Divis Laboratories, Welspun India, AB Fashion, Torrent Pharmaceuticals, Reliance Communications & SML Isuzu.

  • Buy Capital First , PFC, Torrent Pharma; sell Bharti Airtel, Tata Motors DVR: Ashwani Gujral Mar 20, 2017 09:38 AM IST

    Buy Capital First , PFC, Torrent Pharma; sell Bharti Airtel, Tata Motors DVR: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Capital First , Power Finance Corporation and Torrent Pharma and sell Bharti Airtel and Tata Motors DVR.

  • Buy Whirlpool of India, Torrent Pharmaceuticals, Bharat Financial Inclusion: Ashwani Gujral Mar 17, 2017 03:44 PM IST

    Buy Whirlpool of India, Torrent Pharmaceuticals, Bharat Financial Inclusion: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Whirlpool of India, Torrent Pharmaceuticals and Bharat Financial Inclusion.

  • Divis Lab, Cipla, Strides Shasun to get astro support: Gupta Mar 08, 2017 12:11 PM IST

    Divis Lab, Cipla, Strides Shasun to get astro support: Gupta

    According to Satish Gupta of astrostocktips, pharma stocks like Divis Lab, Cipla, Alembic Pharma, Strides Shasun, Ajanta Pharma and Torrent Pharma will get astro support.

  • Buy Kotak Mahindra Bank, NMDC: Mitessh Thakkar Mar 08, 2017 11:32 AM IST

    Buy Kotak Mahindra Bank, NMDC: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com is of the view that one can buy Kotak Mahindra Bank and NMDC.

  • Buy Torrent Pharma, Wockhardt, HUL; sell Canara Bk: Thakkar Feb 28, 2017 09:49 AM IST

    Buy Torrent Pharma, Wockhardt, HUL; sell Canara Bk: Thakkar

    Mitessh Thakkar of miteshthacker.com suggests buying Torrent Pharma, Wockhardt and Hindustan Unilever and aadvises selling Canara Bank and IDFC Bank.

  • Bull's Eye: Buy PNB, Torrent Pharma, GMDC; sell IDBI Bank Feb 28, 2017 07:52 AM IST

    Bull's Eye: Buy PNB, Torrent Pharma, GMDC; sell IDBI Bank

    Gaurav Ratnaparkhi of Sharekhan advises buying Kaveri Seed Company with a target of Rs 489.

Sections